Classification, imaging, biopsy and staging of osteosarcoma

Indian Journal of Orthopaedics

Volumn 48, Issue 3, 2014, Pages 238-246

  Kundu, Zile Singh ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

biopsy; Enneking staging; imaging; Osteosarcoma

Indexed keywords

EID: 84901716587     PISSN: 00195413     EISSN: 19983727     Source Type: Journal    
DOI: 10.4103/0019-5413.132491     Document Type: Conference Paper

References (53)

1. Rosenberg AE. Bone, joints and soft tissue tumors. In: Kumar V, Abbas AK, Fausto N, Aster JC, editors. Robins and cotran pathologic basis of disease. 8 th ed. Philadelphia: WB Saunders; 2010. p. 1203-56.
2. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. World Health Organization, classification of tumours: Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2013.
3. Wold LE, Adler CP, Sim FH, Unni KK. Atlas of orthopaedic pathology, 2 nd ed. Saunders: Philadelphia-London; 2003. p. 179-85.
4. Jaffe HL. Tumors and tumors like conditions of the bones and joints. Philadelphia: Lea and Febiger; 1958.
5. Unni KK. Inwards CY Bone tumors: General aspects and data on 10, 165 cases. 6 th ed. Philadelphia: Lippincott Williams and Wilkins; 2010.
6. Lichtenstein L. Bone tumors. 4 th ed. St. Louis: Mosby; 1972.
7. Heck RK Jr. Malignant bone tumors. In: Canale ST, Beaty JH, editors. Campbell's Operative Orthopedics. Missouri: Mosby Year Book; 2008. p. 901-38.
8. Dorfman HD, Czerniak B. Bone tumors. St. Louis: Mosby; 1998.
9. Campanacci M. Bone and soft tissue tumours: Clinical features, imaging, pathology and treatment. 2 nd ed. Vienna: Springer-Verlag; 1999.
10. Bacci G, Ferrari S, Lari S, Mercuri M, Donati D, Longhi A. Osteosarcoma of the limb: Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg 2002;84:88-92.
11. Bacci G, Ferrari S, Longhi A. Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma. J Clin Oncol 2003;21;4662-6.
12. Bacci G, Longhi A, Varsari M. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15 years experience in 789 patients treated at a single institution. Cancer 2006;106:1154-64.
13. Huvos AG, Woodard HQ, Cahan WG, Higinbotham NL, Stewart FW, Butler A, et al. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer 1985; 55:1244-55. (Pubitemid 15143400)
14. Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C A et al. Radiation dose, chemotherapy and risk of osteosarcoma after solid tumor during childhood. Int J Cancer 1998;77:370-7. (Pubitemid 28299872)
15. Tucker MA, D'Angio GJ, Boice JD Jr, Strong LC, Li FP, Stovall M, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Eng J Med1987; 317: 588-93. (Pubitemid 17126781)
16. Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis. Analytic review of 46 cases. J Artharoplasty 2006; 21: 311-23.
17. Resnick D, Kransdorf MJ. Tumors and tumor-like lesions of bone: Radiographic principles. In: Bone and joint imaging. Elsevier Saunders; Philadelphia Pennsylvania 3 rd ed. 2005. p. 1109-98.
18. Resnick D. Tumors and tumor-like lesions of bone: Radiographic principles. In: Resnick D editor. Diagnosis of bone and joint disorders. Saunders; Philadelphia Pennsylvania 4 th ed. 2002. p. 3745-4128.
19. Vanel D, Henry AM, Lumbroso J, Lemalet E, Couanet D, Piekarski JD, et al. Pulmonary evaluation of patients with osteosarcoma: Role of standard radiography, tomography, CT, Scintigraphy and tomoscintigraphy. Am J Roentgenol 1984;143:519-23. (Pubitemid 14066649)
20. Brown KT, Kattapuram SV, Rosenthal DI. Computed tomography analysis of bone tumors: Patterns of cortical destruction and soft tissue extension. Skeletal Radiol 1986;15:448-51. (Pubitemid 16038546)
21. Kenney PJ, Gilula LA, Murphy WA. The use of computed tomography to distinguish osteochondroma and chondrosarcoma. Radiology 1981;139:129-37. (Pubitemid 11138811)
22. Aisen AM, Martel W, Braunstein EM, McMillin KI, Philips WA, Kling TF. MRI and CT evaluation of primary bone and soft-tissue tumors. Am J Roentgenol 1986;146:749-56. (Pubitemid 16117267)
23. Rubin DA. Magnetic resonance imaging: Practical considerations. In: Resnick D, Kransdorf MJ, editors. Bone and joint imaging. 3 rd ed. Philadelphia Pennsylvania: Elsevier Saunders; 2005. p. 118-32.
24. Bohndorf K, Reiser M, Lochner B, Feaux DL, Steinbrich W. Magnetic resonance imaging of primary tumors and tumor-like lesions of bone. Skeletal Radiol 1986;15:511-7. (Pubitemid 16010647)
25. Holscher HC, Bloem JL, Vanel D, Hermans J, Nooy MA, Taminiau AH, et al. Osteosarcoma: Chemotherapy induced changes at MR imaging. Radiology 1992;182:839-44.
26. Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, et al. Osteosarcoma: Preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion-and perfusion-weighted magnetic resonance imaging. Invest Radiol 2006;41:618-23. (Pubitemid 44284169)
27. Schneider R. Radionuclide technique. In: Resnick D, Kransdorf MJ, editors. Bone and joint imaging. 3 rd ed, Philadelphia Pennsylvania: Elsevier Saunders; 2005. p. 86-117.
28. Huang TL, Liu RS, Chen TH, Chen WY, Hsu HC, Hsu YC. Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma. J Chin Med Assoc 2006;69:372-6. (Pubitemid 44355651)
29. Hongtao L, Hui Z, Bingshun W, Xiaojin W, Zhiyu W, Shuier Z, et al. 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: A meta-analysis. Surg Oncol 2012;21:165-70.
30. Bajpai J, Kumar R, Sreenivas V, Sharma MC, Khan SA, Rastogi S, et al. Prediction of chemotherapy response by PET-CT in osteosarcoma: Correlation with histologic necrosis. J Pediatr Hematol Oncol 2011;33:271-8.
31. Im HJ, Kim TS, Park SY, Min HS, Kim JH, Kang HG, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging 2012;39:39-49.
32. Cistaro A, Lopci E, Gastaldo L, Fania P, Brach DP, Fagioli F. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma. Pediatr Blood Cancer 2012;59:1206-10.
33. Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, et al. Procedure Guideline for SPECT/CT Imaging 1.0. J Nucl Med 2006;47:1227-34. (Pubitemid 47544920)
34. Cook GJ, Maisey MN, Fogelman I. Fluorine-18-FDG PET in Paget's disease of bone. J Nucl Med 1997;38:1495-7. (Pubitemid 27386220)
35. Bickels J, Jelinek JS, Shmookler BM, Neff RS, Malawer MM. Biopsy of musculoskeletal tumors. Clin Orthop Rel Res 1999;36:212-9.
36. Mitsuyoshi G, Naito N, Kawai A, Kunisada T, Oshida A, Yanai H, et al. Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol 2006;94:21-7. (Pubitemid 43967718)
37. Ottolenghi CE. Diagnosis of orthopaedic lesions by aspiration biopsy. J Bone Joint Surg Am 1955;37:443-64.
38. Murphy WA, Destouet JM, Gilula LA. Percutaneous skeletal biopsy. A procedure for radiologists-results, review and recommendations. Radiology 1981;139:545-9. (Pubitemid 11072774)
39. Moore TM, Meyers MH, Patzakis MJ, Terry R, Harvey JP Jr. Closed biopsy of musculoskeletal lesions. J Bone Joint Surg Am 1979;61:375-80. (Pubitemid 9154276)
40. Skrzynski MC, Biermann JS, Montag A, Simon MA. Diagnostic accuracy and charge savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1996;78:644-9. (Pubitemid 26154249)
41. Lawrence Y, Nelson SD, Seeger LL, Eckardt JJ, Eilber FR. Primary musculoskeletal neoplasms: Effectiveness of core needle biopsy. Radiology 1999;212:682-6. (Pubitemid 29410967)
42. Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer 2000;89:2677-86.
43. Jelinek JS, Murphey MD, Welker JA. Diagnosis of primary bone tumor with image-guided percutaneous biopsy: Experience with 110 Tumors. Radiology 2002;223:731-7. (Pubitemid 34547590)
44. Wu JS, Goldsmith JD, Horwich PJ, Shetty SK, Hochman MG. Bone and soft-tissue lesions: What factors affect diagnostic yield of image-guided core-needle biopsy? Radiology 2008;248:962-70.
45. Carrino JA, Khurana B, Ready JE, Silverman SG, Winalski CS. Magnetic resonance imaging-guided percutaneous biopsy of musculoskeletal lesions. J Bone Joint Surg Am 2007;89:2179-87. (Pubitemid 47606164)
46. Pollock RC, Stalley PD. Biopsy of musculoskeletal tumours:Beware. ANZ J Surg 2004;74:516-9.
47. Hogendoorn PC, Athanasoul N, Bielack S, De Alava E, Dei Tos AP, Ferrari S, et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Ann Oncol 2010;21:204-13.
48. Jalgaonkar A, Dawson-Bowling SJ, Mohan AT, Spielberg B, Saifudin A, Pollock R, et al. Identification of the biopsy track in musculoskeletal tumour surgery: A novel technique using India ink. Bone Joint J 2013;95:250-3.
49. Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 1982;64:1121-7. (Pubitemid 13244005)
50. Mankin HJ, Mankin CJ, Simon MA. The hazards of biopsy, revisited: Members of Musculoskeletal Society. J Bone Joint Surg 1996;64:656-63.
51. Broders AC. Squamous cell epithelioma of the lip: A study of 537 cases. JAMA 1920;74:656-64.
52. Inwards CY, Unni KK. Classification and grading of bone sarcomas. Hematol Oncol Clin North Am 1995;9:545-69.
53. Wolf RE, Enneking WF. The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am 1996;27:473-81. (Pubitemid 26187669)